Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition
Launched by JOHANNES GUTENBERG UNIVERSITY MAINZ · Nov 4, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The MICRO-SNAPE registry is an important clinical study that aims to gather information about patients with coronary microvascular disease and coronary vasospasm, which are conditions that affect small blood vessels in the heart. This study is being conducted in various hospitals across Europe and North America and is currently looking for participants. If you are between the ages of 65 and 74 and have had specific heart tests that measure blood flow and pressure in your coronary arteries, you might be eligible to join.
Participants in this study will help researchers understand how blood flow and pressure change in the heart's small vessels under different conditions. This will involve some tests that have already been done, and your participation might help improve future treatments for these heart conditions. Importantly, this study is not open to individuals under 18 years old or those who are experiencing serious heart issues at the time. If you choose to participate, you will be contributing to valuable research that could benefit many others with similar heart problems in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who underwent combined measurements of coronary pressure and flow in at least 1 native coronary artery in response to endothelium dependent and independent vasodilators.
- Exclusion Criteria:
- • Hemodynamic instability
- • Age \<18 years
About Johannes Gutenberg University Mainz
Johannes Gutenberg University Mainz, a leading research institution in Germany, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research and education to address critical health challenges. Its commitment to ethical standards and scientific rigor ensures that clinical trials are conducted with the utmost integrity, aiming to translate research findings into effective therapies and improved patient outcomes. Through its robust infrastructure and expert faculty, Johannes Gutenberg University Mainz plays a pivotal role in enhancing the landscape of clinical research and contributing to global health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mainz, Rheinland Pfalz, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported